The i-PBMC efficacy assay platform was used to inoculated NPSG mice with PBMC cells from healthy adult donors

Home

Service

• Humanized model of the immune system

  • iHuPBMC-T

  • iHuPBMC-NK

  • iHuPBMC-B

  • PBMC-LT

  • CD34+ HSC

  • Winn model

  • iHuPBMC-MHC/KO

  • iHuPBMC-OncVax

  • PBMC mixed inoculation model

• In vivo tumor experimental platform

  • CDX

  • iHuPDX

  • Non-GLP Toxicology

  • PK/PD

  • Brain in situ model

  • Other in situ models

  • Hematologic tumor model system inoculation

  • Creation of high interstitial tumor models

• In vitro killing experiment platform

  • Immune co-culture killing model

  • CDC

  • In vitro killing experiment platform

  • IC50

  • PDC High-Throughput In Vitro Pharmacodynamics

  • 3D organoids

  • ADCC

  • T cell-mediated killing experiment

• Mouse-derived immune system model

  • Homogeneous Model

  • SCID mouse NK efficacy model

  • Homologous Models in Genetic Engineering

• Tumor vaccine

  • PBMC-OncVax tumor vaccine model

  • MHC humanized mouse model

• Cell therapy

  • Car-T

  • Car-T-MHC/KO

  • Car-NK

  • Host anti-graft reaction (HVG)

• In vitro testing platform

  • ELISpot

  • ELISA

  • FACS

  • Luminex

  • qPCR

• Non-GLP Toxicology Platform

  • GVHD experimental platform

  • Non-GLP Toxicology Platform

  • Immunogenicity testing

• Non-tumor model and drug efficacy evaluation platform

  • Systematic Vaccination Model

  • Non-tumor model and drug efficacy evaluation platform

  • Skin injury model

  • Stroke model

  • Liver fibrosis model

  • Diabetes model

  • Gouty Arthritis (GA) Model

  • Pulmonary fibrosis model

  • Systemic lupus erythematosus (SLE) model

  • Inflammatory Bowel Disease (IBD) model

  • Rheumatoid Arthritis (RA) Model

Model

• PDX model

  • PDX model

  • Head and neck cancer

  • Eye cancer

  • Lung cancer

  • Human breast cancer

  • Esophageal cancer in humans

  • Human gastric cancer

  • Colorectal cancer

  • Human liver cancer

  • Bile duct cancer

  • Gallbladder cancer

  • Human pancreatic cancer

  • Human kidney cancer

  • Human Bladder Cancer

  • Ureteral cancer

  • Prostate cancer

  • Uterine cancer

  • Cervical cancer in women

  • Human Ovarian Cancer

  • Human skin cancer

  • sarcoma

  • Human Nervous System Cancer

  • Embryonal carcinoma

  • Human Lymphoma

  • Human leukemia

  • Multiple Myeloma

  • Adrenal gland

  • Mesothelioma

  • Other people

• CDX model

  • CDX model

  • Head and neck cancer

  • Eye cancer

  • Lung cancer

  • Human breast cancer

  • Esophageal cancer in humans

  • Human gastric cancer

  • Colorectal cancer

  • Human liver cancer

  • Bile duct cancer

  • Gallbladder cancer

  • Human pancreatic cancer

  • Human kidney cancer

  • Human Bladder Cancer

  • Ureteral cancer

  • Prostate cancer

  • Uterine cancer

  • Cervical cancer in women

  • Human Ovarian Cancer

  • Human skin cancer

  • sarcoma

  • Human Nervous System Cancer

  • Embryonal carcinoma

  • Human Lymphoma

  • Human leukemia

  • Multiple Myeloma

  • Adrenal gland

  • Mesothelioma

  • Other people

• Homogeneous Model

  • Homogeneous Model

  • Head and neck cancer

  • Eye cancer

  • Lung cancer

  • Breast cancer

  • Stomach cancer

  • Liver cancer

  • Bile duct cancer

  • Gallbladder cancer

  • Pancreatic cancer

  • Kidney cancer

  • Bladder cancer

  • Ureteral cancer

  • Prostate cancer

  • Uterine cancer

  • Cervical cancer

  • Ovarian cancer

  • Esophageal cancer

  • Skin cancer

  • sarcoma

  • Nervous System Cancer

  • Embryonal carcinoma

  • Lymphoma

  • Leukemia

  • Multiple Myeloma

  • Adrenal gland

  • Mesothelioma

  • Other

  • Colorectal cancer

Databases

About Us

• Company Profile

• Team Introduction

• History

• Recruiting Talents

• Contact Us

• Research findings

News

• Company News

• Industry news